Novel clinical trial designs incorporating genomics for developing anti-cancer drugs: Olaparib in prostate cancer

Date 10 October 2016
Event ESMO 2016 Congress
Session Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents
Topics Cytotoxic agents
Prostate Cancer
Therapy
Biological therapy
Presenter Johann de Bono
Authors J.S. de Bono
  • Royal Marsden Hospital NHS Foundation Trust, SW3 6JJ - London/GB